5-[4-(4,5-Dihydro-oxazol-2-yl)-phenoxy]-1-(5-methyl-thiophen-2-yl)-pentan-1-one

ID: ALA166427

Chembl Id: CHEMBL166427

PubChem CID: 513094

Max Phase: Preclinical

Molecular Formula: C19H21NO3S

Molecular Weight: 343.45

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(C(=O)CCCCOc2ccc(C3=NCCO3)cc2)s1

Standard InChI:  InChI=1S/C19H21NO3S/c1-14-5-10-18(24-14)17(21)4-2-3-12-22-16-8-6-15(7-9-16)19-20-11-13-23-19/h5-10H,2-4,11-13H2,1H3

Standard InChI Key:  IVFUUGAUZLABJK-UHFFFAOYSA-N

Associated Targets(Human)

HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human rhinovirus sp. (1587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Poliovirus 1 (1274 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Poliovirus 2 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Poliovirus 3 (200 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 343.45Molecular Weight (Monoisotopic): 343.1242AlogP: 4.27#Rotatable Bonds: 8
Polar Surface Area: 47.89Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.99CX LogP: 4.41CX LogD: 4.41
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.53Np Likeness Score: -0.90

References

1. Massa S, Corelli F, Artico M, Mai A, Ragno R, De Montis A, Loi AG, Corrias S, Marongiu ME, La Colla P..  (1995)  [[[(Thienylcarbonyl)alkyl]oxy]phenyl]- and [[[(pyrrylcarbonyl)alkyl]oxy]phenyl]oxazoline derivatives with potent and selective antihuman rhinovirus activity.,  38  (5): [PMID:7877145] [10.1021/jm00005a007]
2. Madia VN, Messore A, Pescatori L, Saccoliti F, Tudino V, De Leo A, Scipione L, Fiore L, Rhoden E, Manetti F, Oberste MS, Di Santo R, Costi R..  (2019)  In Vitro Antiviral Activity of New Oxazoline Derivatives as Potent Poliovirus Inhibitors.,  62  (2): [PMID:30512950] [10.1021/acs.jmedchem.8b01482]

Source